Ovarian cancer is a highly invasive and metastatic disease with a poor prognosis if diagnosed at an advanced stage, which is often the case. Recent studies argue that ovarian cancer cells that have undergone epithelial to mesenchymal transition (EMT) acquire aggressive malignant properties, but the relevant molecular mechanisms in this setting are not well understood. Here we report findings from an siRNA screen that identified the homeobox transcription factor ALX1 as a novel regulator of EMT.
Introduction
Ovarian cancer is a highly metastatic disease and the most lethal of the gynecologic malignancies. Despite advances in cytotoxic therapies for numerous types of cancer, the current therapies available to ovarian cancer patients in advanced stages have little effect, as evidenced by the poor 5-yr survival rate (1, 2) . To provide insight that will enable the development of new therapeutic strategies, it is crucial to elucidate the molecular mechanisms that promote the invasive and metastatic properties of ovarian cancer cells. Recent studies have demonstrated that a morphologic conversion, known as epithelial to mesenchymal transition (EMT), is associated with the acquisition of malignant characteristics in ovarian cancer cells (3) (4) (5) (6) (7) (8) .
EMT is a complex multi-step process that occurs during embryonic development, tumor progression, and tissue fibrosis (9, 10) . During EMT, epithelial cells lose many of their epithelial characteristics and adopt a mesenchymal appearance and mesenchymal characteristics, such as increased motility and invasiveness. Dynamic changes in gene expression and cytoskeletal re-organization are often observed during the process of EMT (11) . One of the hallmarks of EMT is the suppression of E-cadherin, a transmembrane protein essential for cell-cell adhesions. The loss of E-cadherin expression not only disrupts cell-cell adhesion but also activates multiple pathways that induce cellular dissemination, invasion and metastasis (12) .
Extensive studies have revealed that EMT is governed by a variety of regulatory networks. EMT is triggered by extracellular stimuli, such as transforming growth factor β (TGF-β), fibroblast growth factor (FGF), hepatocyte growth factor (HGF) and endothelin-1 (ET-1) (13, 14) . The signaling pathways activated by these factors induce changes in cytoskeletal organization and disrupt cell-cell junctions. In addition to these on April 14, 2017. © 2013 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on January 3, 2013; DOI: 10.1158/0008-5472. CAN-12-2377 signaling pathways, transcription factors, such as Snail, Slug, Twist, Zeb1 and SIP1, have been found to play crucial roles in promoting EMT (15) . Among them, Snail is the most extensively studied and has been associated with tumor progression (16) . Snail is a zinc-finger transcription factor that binds to E-box sequences located in the promoter regions of target genes (17, 18) . Snail can also regulate transcription by modifying local chromosomal structures via the recruitment of histone deacetylase 1 (HDAC1) and HDAC2, as well as the co-repressor Sin3A (19) . In addition to the well-known EMT inducers, recent studies have unveiled novel EMT-related transcription factors, such as HOXB7 (20), SIX1 (21,22), FOXQ1 (23,24), and FOXM1 (25). These findings indicate that EMT is regulated by a diverse set of transcription factors. Thus, the identification of additional factors will give further insight into the molecular mechanisms regulating EMT.
To search for novel regulators of EMT, we performed a limited siRNA screen and found that Aristaless-like homeobox1 (ALX1), also known as Cart1 (26, 27) , is important for the induction of morphological changes in ovarian cancer cells. Previous studies have shown that ALX1 is required for neuronal or craniofacial development (28, 29) , but the detailed physiological role of ALX1 remains largely unknown. In this report, we demonstrate that ALX1 induces EMT and cell invasion in ovarian cancer cells by promoting Snail expression.
Materials and Methods
Materials and Methods have also been described in Supplementary Materials. (31) (32) (33) . Forty-eight transcription factors were manually selected and 2 siRNAs targeting each gene were transfected to SKOV3 cells cultured in 24-well plates. Seventy-two hour later, cells were fixed and stained with rhodamine-conjugated phalloidin. Pictures were taken and morphological changes were evaluated by 2 independent researchers.
Cells, antibodies and chemicals

Luciferase assay
The previously reported promoter region for Snail (-1558/+92) (34) was amplified and cloned into the pGL4 vector (Promega). 293T cells were transfected with the pGL4-Snail/promoter together with pQCXIP-GFP-ALX1 and pRTK-Luc to normalize transfection efficiency. Forty-eight hours later, the activities of Firefly luciferase and Renilla luciferase were measured using the Dual Luciferase Reporter Assay System (Promega). Luciferase activity was measured in triplicate and three independent experiments were performed. To measure luciferase activity in the absence of ALX1 expression, SKOV3 cells were transfected with control or ALX1 siRNA together with pRTK-Luc and pGL4-Snail/promoter. Seventy-two hours later, luciferase activities were measured.
Statistical analysis
Statistical analysis for cell invasion, colony formation, and tumor formation in mice was performed using Student's t-test. P<0.05 was considered statistically significant. The association between ALX1 expression and tumor stage was determined by Chi-squared-test. The correlation between ALX1 and Snail expression, or ALX1 and Slug expression in cancer tissues was determined by Pearson's correlation coefficient. 
Results
Depletion of ALX1 induces reversion of EMT
To search for novel transcription factors associated with EMT and aggressive characteristics in ovarian cancer cells, we performed a limited siRNA screen. We manually selected 48 transcription factors that were previously reported to exhibit increased expression in ovarian cancer (32, 33) . SKOV3 cells were transfected with siRNAs targeting these transcription factors and changes in cellular morphology were examined. We predicted that the depletion of genes relevant to EMT would induce an epithelial morphology with tight cell-cell adhesion in SKOV3 cells. In this screen, we discovered that the transfection of 2 different ALX1-targeting siRNAs induced morphological changes in SKOV3 cells. Thus, we decided to investigate roles for ALX1 in the induction of EMT and the acquisition of aggressive characteristics in ovarian cancer cells.
We first evaluated the expression levels of ALX1 mRNA in ovarian cancer cell lines using quantitative RT-PCR analysis. The expression of ALX1 mRNA was greatest in the ES-2, HEY and SKOV3 cells (Fig. 1A ). Interestingly, the expression level of ALX1 mRNA was related with the malignant characteristics of ovarian cancer cells. ES-2, HEY and SKOV3 cells were more invasive than other ovarian cancer cell lines and were able to grow under anchorage-independent conditions (Fig. S1) . To determine the expression of ALX1 in ovarian cancer, we performed in situ hybridization using tissue microarrays. We found that strong expression of ALX1 mRNA was observed in some cancer tissues, and the expression was correlated with tumor stage (Fig. 1B) . We then examined the effects of ALX1 depletion in the cell lines with high ALX1 expression. ALX1 depletion induced the recovery of cell-cell adhesions and the cellular morphology became more like that of epithelial cells (Fig. 1C) . Immunostaining analysis revealed that knocking down ALX1 expression induced a clear recovery of E-cadherin localization in HEY and SKOV3 cells, but not in ES-2 cells (Fig. 1C) . We speculated that the cells had undergone a reversion of EMT by ALX1 depletion in HEY and SKOV3 cells. To test this hypothesis, the expression levels of epithelial and mesenchymal markers were examined. ALX1 mRNA expression was sufficiently suppressed by both siRNAs (Fig.   1D ). The up-regulation of E-cadherin and the down-regulation of N-cadherin and vimentin were detected at both the mRNA and the protein levels in HEY and SKOV3 cells ( Fig. 1D and 1E ). However, ES-2 cells did not show any changes in expression of these markers by ALX1 knockdown (Fig. 1D and 1E ). We performed rescue experiment to exclude the possibility of off-target effects of siRNAs. SKOV3 cells that constitutively expressed GFP-ALX1 or siRNA-resistant GFP-ALX1 (ALX-Res#2) were established by retrovirus infection. ALX1 siRNA effectively ablated exogenously expressed wild-type GFP-ALX1, but not siRNA-resistant GFP-ALX1 (Fig. S2) . Changes in expression of the marker proteins were not observed in cells that expressed siRNA-resistant GFP-ALX1 (Fig. S2) . These results indicate that ALX1 is crucial for SKOV3 and HEY cells to maintain mesenchymal characteristics, but ES-2 cells may have additional factors that prevent cells from undergoing reversion of EMT by ALX1 depletion.
ALX1 regulates cell invasion and anchorage independent growth.
EMT is associated with malignant properties, such as invasion and anchorage-independent growth (35, 36) . We tested whether ALX1 was required for these properties in ovarian cancer cells. To assess cell invasiveness, we used Matrigel-coated Fig. 2A) . The reduced invasiveness by ALX1 depletion is not due to the impaired viability of cells because cell proliferation was not inhibited by ALX1 siRNA-transfection (Fig. S3) . We next assessed anchorage-independent cell growth in the ALX1-depleted cells. As shown in figure 2B , the silencing of ALX1 expression suppressed colony formation in soft agar. To test whether the inhibition of ALX1 expression affected cancer cell growth in vivo, we generated SKOV3 cells that constitutively expressed shRNA targeting either luciferase (shCtrl) or ALX1 (shALX1).
ALX1 mRNA was reduced and E-cadherin expression was induced in shALX1 cells ( Exogenous expression of ALX1 confers malignant phenotype.
We next determined whether the exogenous expression of ALX1 confers a more malignant phenotype to ovarian cancer cells. In addition to a homeodomain in the central region of the protein, ALX1 has a conserved amino acid stretch known as the aristaless domain or OAR domain (Fig. 3A) . We generated SKOV3 cells that ΔOAR localized to the nucleus, but Δhomeo diffusely localized to both the cytoplasm and the nucleus (Fig. 3B ). FL and ΔOAR SKOV3 cells exhibited more elongated and spindle-like shapes than the GFP and Δhomeo SKOV3 cells (Fig. 3B) . The expression of E-cadherin was eliminated in FL and ΔOAR SKOV3 cells, but not in GFP and Δhomeo SKOV3 cells (Fig. 3C ). In addition, the expression of N-cadherin and vimentin was up-regulated in FL and ΔOAR SKOV3 cells (Fig. 3C ). We next assessed the effects of ALX1 expression on invasion and anchorage-independent growth. Both FL and ΔOAR SKOV3 cells were significantly more invasive than the GFP and Δhomeo SKOV3 cells (Fig. 3D) . Furthermore, expression of FL and ΔOAR clearly promoted the anchorage-independent growth of SKOV3 cells (Fig. 3E) . Promotion of EMT, anchorage-independent growth and invasion by ALX1 expression was also observed using additional ovarian cancer cell line, NOS3 (Fig. S4 ). These results demonstrate that ALX1 is associated with aggressive phenotype of ovarian cancer cells.
Exogenous expression of ALX1 in non-tumorigenic cells induces EMT
To further extend our analysis of the role of ALX1 in EMT, we determined whether ALX1 can induce EMT in non-tumorigenic epithelial cells. MCF10A cells are non-transformed mammary epithelial cells characterized by well-organized cell-cell junctions. We generated GFP, FL, Δhomeo, and ΔOAR MCF10A cells by retroviral infection. Both GFP and Δhomeo MCF10A cells maintained a cobblestone-like morphology that was similar to parental cells (Fig. 4A ). In contrast, FL and ΔOAR MCF10A cells appeared elongated and the cell-cell junctions were disrupted (Fig. 4A ).
E-cadherin was localized along the cell-cell junctions in GFP and Δhomeo MCF10A cells, but was absent in FL and ΔOAR MCF10A cells ( cytoskeleton is often observed during EMT. Both GFP and Δhomeo MCF10A cells primarily exhibited cortical F-actin formation along cell-cell junctions, whereas the clear organization of actin stress fibers across the cell was observed in the FL and ΔOAR MCF10A cells (Fig. 4C) . Consistent with the observed changes in actin cytoskeleton organization, the formation of focal adhesions was evident in FL and ΔOAR MCF10A cells (Fig. 4C ). ALX1-induced EMT was further confirmed by immunoblot analysis. FL and ΔOAR MCF10A cells exhibited a decrease in E-cadherin expression that was concomitant with an increase in the expression of both N-cadherin and vimentin (Fig.   4D ). The expression of ALX1 also promoted migration and invasion of MCF10A cells ( Fig. 4E and 4F ).
ALX1 regulates Snail expression
To gain further insight into the molecular mechanisms by which ALX1 regulates EMT and malignant conversion, we aimed to identify transcription factors whose expression is regulated by ALX1. RNA was extracted from SKOV3, HEY and ES-2 cells that had been transfected with ALX1-targeting siRNA, and the mRNA expression of EMT-related transcription factors was examined by RT-PCR. Among the transcription factors examined, Snail mRNA was decreased by the knock-down of ALX1 in SKOV3 and HEY cells, but not in ES-2 cells (Fig. 5A) . The reduced expression of Snail protein in HEY and SKOV3 cells transfected with ALX1 siRNA was verified by immunoblot (Fig. 5B) . Snail was localized in the nucleus of SKOV3 cells that were transfected with control siRNA (Fig. 5C ). ALX1 knock-down suppressed nuclear Snail expression, which was concomitant with an increase in E-cadherin expression along cell-cell junctions (Fig. 5C ).
We next determined whether the exogenous expression of ALX1 up-regulates Snail As shown in figure 5D , Snail expression was increased in FL and ΔOAR cells compared with GFP and Δhomeo cells. We also performed luciferase assays to determine whether Snail promoter activity was regulated by ALX1 expression. 293T cells were transiently co-transfected with full-length ALX1 and a reporter construct in which the human Snail promoter region was cloned upstream of firefly luciferase (pGL4-Snail/promoter).
Exogenous expression of ALX1 increased Snail promoter activity approximately 3.3 fold (Fig. 5E ). In addition, the transfection of ALX1 siRNA into SKOV3 cells decreased promoter activity 40-50% compared with that of luciferase siRNA (Fig. 5F ). These results indicate that ALX1 induces the transcription of the Snail gene. Finally, we examined whether ALX1 expression was related with Snail expression in ovarian cancer.
The expression levels of ALX1 and Snail mRNA were evaluated in 19 ovarian cancer tissues by quantitative RT-PCR. As shown in figure 5G, we observed a significant correlation between ALX1 and Snail expression. However, the expression of Slug, a homolog of Snail, did not correlate with ALX1 expression (Fig. 5G) .
Snail is required for ALX1-mediated EMT and cell invasion
If Snail expression is crucial for the ALX1-mediated EMT, then depletion of Snail is expected to reverse the morphological changes induced by ALX1 expression. To test this possibility, MCF10A cells that constitutively expressed GFP-ALX1 were transfected with Snail siRNA and changes in the expression of EMT-related proteins were examined.
Immunofluorescence analysis showed that Snail depletion clearly restored E-cadherin localization to the cell-cell junctions (Fig. 6A) 
and the decrease in both N-cadherin and vimentin expression were confirmed by immunoblot analysis in Snail knock-down cells (Fig. 6B) . We next examined whether Snail expression was critical for ALX1-mediated EMT and cell invasion in SKOV3 cells.
Similar to the results obtained from MCF10A cells, silencing Snail expression in ALX1-expressing SKOV3 cells restored epithelial properties, as indicated by the increased expression of epithelial markers (Fig. 6C) . In addition, the invasive phenotype of ALX1-expressing SKOV3 was suppressed by Snail knock-down (Fig. 6D) .
To further confirm the requirement of Snail for ALX1-dependent EMT, we generated 
Accumulating evidence indicates that EMT-associated transcription factors confer cancer cells with malignant characteristics, such as invasion, metastasis, and resistance to chemotherapy (15) . In this study, we determined that the exogenous expression of ALX1 knockout mice exhibit defective neural tube closure and limb girdle development (28, 38) . These studies clearly demonstrate that ALX1 plays an essential role in mammalian development, but how ALX1 controls embryonic development remains largely unknown. Recent studies have shown that ALX1 is part of a gene regulatory network that is required for the development of sea urchins (39) . ALX1 regulates the expression of genes, such as Twist, that induce EMT in primary mesenchyme cells (40) . 
